Aitiabio
1 known investors
Aitia develops a causal AI platform called Gemini Digital Twin that creates in silico disease models using patient data and simulation technology to support drug discovery and development for biopharma companies across oncology, neurodegenerative, immunological, and cardiometabolic diseases.
AI & Machine LearningBiotechDeep Tech